Long-Term Safety Study of KW-6002 (Istradefylline) in Parkinson's Disease Patients

NCT00957203 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

308

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: Istradefylline

Sponsor

Kyowa Kirin Co., Ltd.